Indication
Acne rosacea
Acne rosacea, commonly referred to simply as rosacea, is a chronic inflammatory dermatologic disorder that primarily targets the central facial skin, most frequently affecting fair-skinned adults between the ages of 30 and 50. Read more about Acne rosacea
71 drugs 41 manufacturers
Drugs that treat it
Common Acne rosacea therapies.
IVERMECTIN
ZILXI (minocycline HCl)
RHOFADE (oxymetazoline HCl)
ZILXI (minocycline HCl)
EPSOLAY (benzoyl peroxide)
DAZOMON (brimonidine tartrate)
RHOFADE (oxymetazoline HCl)
ZILXI (minocycline HCl)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAcne rosacea, commonly referred to simply as rosacea, is a chronic inflammatory dermatologic disorder that primarily targets the central facial skin, most frequently affecting fair-skinned adults between the ages of 30 and 50.
Pathophysiologically driven by innate immune dysregulation, neurovascular hyperreactivity, and microscopic Demodex mite proliferation, the disease manifests with persistent centrofacial erythema, recurrent flushing, telangiectasias, and inflammatory papules and pustules.
Unlike acne vulgaris, acne rosacea characteristically lacks comedones and may progress to include secondary complications such as ocular involvement or phymatous tissue hypertrophy, particularly rhinophyma.
- nih.gov
Acne rosacea, commonly referred to simply as rosacea, is a chronic inflammatory dermatologic disorder that primarily targets the central facial skin, most frequently affecting fair-skinned adults between the ages of 30 and 50 Pathophysiologically driven by innate immune dysregulation, neurovascular hyperreactivity, and microscopic Demodex mite proliferation, the disease manifests with persistent centrofacial erythema, recurrent flushing, telangiectasias, and inflammatory papules and pustules Unl...
- medlineplus.gov
Acne rosacea, commonly referred to simply as rosacea, is a chronic inflammatory dermatologic disorder that primarily targets the central facial skin, most frequently affecting fair-skinned adults between the ages of 30 and 50
- nih.gov
Pathophysiologically driven by innate immune dysregulation, neurovascular hyperreactivity, and microscopic Demodex mite proliferation, the disease manifests with persistent centrofacial erythema, recurrent flushing, telangiectasias, and inflammatory papules and pustules
- nih.gov
Unlike acne vulgaris, acne rosacea characteristically lacks comedones and may progress to include secondary complications such as ocular involvement or phymatous tissue hypertrophy, particularly rhinophyma
Personalize your experience
Follow Acne rosacea and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.